Angiotensin Converting Enzyme II Inhibitor

Product Description

Angiotensin Converting Enzyme II Inhibitor
Catalog number: B2010520
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 2 mg
Molecular Weight or Concentration: 428.31 g/mol
Supplied as: Powder
Applications: molecular tool for various ACE2-related research studies
Storage: 2-8°C
Keywords: (S, S)-2-(1-Carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)-ethylamino)-4-methylpentanoic acid, 2( S)-(1( S)-Carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)-ethylamino)-4-methylpentanoic acid, ACE2 Inhibitor
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Jiang F, Yang J, Zhang Y, Dong M, Wang S, Zhang Q, Liu FF, Zhang K, Zhang C.
Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.
Nat Rev Cardiol. 2014 Jul;11(7):413-26.

2: Zheng H, Cao JJ. Angiotensin-Converting Enzyme Gene Polymorphism and Severe
Lung Injury in Patients with Coronavirus Disease 2019. Am J Pathol. 2020
Oct;190(10):2013-2017.

3: Kai H, Kai M. Interactions of coronaviruses with ACE2, angiotensin II, and
RAS inhibitors-lessons from available evidence and insights into COVID-19.
Hypertens Res. 2020 Jul;43(7):648-654.

4: Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human
homolog of angiotensin-converting enzyme. Cloning and functional expression as a
captopril-insensitive carboxypeptidase. J Biol Chem. 2000 Oct
27;275(43):33238-43.

5: Sommerstein R, Kochen MM, Messerli FH, Gräni C. Coronavirus Disease 2019
(COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor
Blockers Have a Biphasic Effect? J Am Heart Assoc. 2020 Apr 7;9(7):e016509.

6: Natesh R, Schwager SL, Sturrock ED, Acharya KR. Crystal structure of the
human angiotensin-converting enzyme-lisinopril complex. Nature. 2003 Jan
30;421(6922):551-4.

7: Rossi GP, Sanga V, Barton M. Potential harmful effects of discontinuing ACE-
inhibitors and ARBs in COVID-19 patients. Elife. 2020 Apr 6;9:e57278.

8: Pan X, Shao Y, Wu F, Wang Y, Xiong R, Zheng J, Tian H, Wang B, Wang Y, Zhang
Y, Han Z, Qu A, Xu H, Lu A, Yang T, Li X, Xu A, Du J, Lin Z. FGF21 Prevents
Angiotensin II-Induced Hypertension and Vascular Dysfunction by Activation of
ACE2/Angiotensin-(1-7) Axis in Mice. Cell Metab. 2018 Jun 5;27(6):1323-1337.e5.

9: Simões e Silva AC, Silveira KD, Ferreira AJ, Teixeira MM. ACE2,
angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis. Br J
Pharmacol. 2013 Jun;169(3):477-92.

10: Deng JL, Jiang YQ, Guo YK, Li HL. Patients taking angiotensin-converting
enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of
severe acute respiratory syndrome coronavirus 2 infection but milder clinical
manifestations? Chin Med J (Engl). 2020 Nov 20;133(22):2650-2652.

Products Related to Angiotensin Converting Enzyme II Inhibitor : SARS-CoV-2